February 2022 – Page 15

Feb 03 2022

Schizophrenia patient in Abu Dhabi successfully completes undergraduate degree

by Clinical Editor

No Comments

Image Credit: Gulf News Abu Dhabi: A 43-year-old woman diagnosed with chronic schizophrenia has been able to get her undergraduate degree following comprehensive treatment at the Shaikh Khalifa …

Feb 03 2022

Uncategorized

With Intent to Harm: The CIA, Schizophrenia and Denmark’s Children

by Clinical Editor

No Comments

It has become common fare to read ghoulish stories of child abuse in institutions supposedly created to care for the vulnerable. Orphanages, homes, …

Feb 02 2022

Uncategorized

Teenagers who smoke cannabis are six times more likely to develop schizophrenia, study claims

by Clinical Editor

No Comments

Teenagers who smoke cannabis less than twice a week are six times more likely to develop schizophrenia than non-smokers, a study has claimed. Researchers from Saint Vincent and the Grenadines,...

Feb 02 2022

Uncategorized

With Intent to Harm: The CIA, Schizophrenia and Denmark’s Children

by Clinical Editor

No Comments

It has become common fare to read ghoulish stories of child abuse in institutions supposedly created to care for the vulnerable. Orphanages, homes, …

Feb 02 2022

Uncategorized

Care for Schizophrenia, Bipolar Disorder Plunged During Pandemic

by Clinical Editor

No Comments

The COVID-19 pandemic brought big care disruptions for those suffering from severe mental illness, a study suggested. In a population-based study of Medicare beneficiaries with schizophrenia or …

Feb 02 2022

Uncategorized

Schizophrenia Symptoms Linked to an Overactive Region of the Brain

by Clinical Editor

No Comments

Neuroscientists have found a link between hotspots of brain overactivity and specific symptoms of schizophrenia. The University of Nottingham res | Clinical And Molecular Dx …

Feb 02 2022

Uncategorized

New Link Between Schizophrenia and Brain Over-Activity Identified

by Clinical Editor

No Comments

Researchers raise the possibility of more targeted treatments for schizophrenia after they demonstrated how over-activity in the hippocampus is linked to some symptoms of the condition.

Feb 01 2022

Uncategorized

Schizophrenia – The Lancet

by Clinical Editor

No Comments

Schizophrenia The Lancet Paranoid Schizophrenia: Signs, Examples, Treatment, and More Healthgrades 8 Questions to Ask Your Doctor About Schizophrenia Healthline Reducing Heterogeneity in Non–Treatment-Resistant and Treatment-Resistant Schizophrenia Psychiatric Times View Full Coverage on Google...

Feb 01 2022

Uncategorized

Dosing underway in Reviva Pharma’s late-stage brilaroxazine study for schizophrenia

by Clinical Editor

No Comments

Reviva Pharmaceuticals (RVPH) announced that the first patients have been dosed in a pivotal Phase 3 study and long-term safety trial to assess Reviva’s new chemical …

Feb 01 2022

Uncategorized

Dosing underway in Reviva Pharma’s late-stage brilaroxazine study for schizophrenia

by Clinical Editor

No Comments

Reviva Pharmaceuticals (RVPH) announced that the first patients have been dosed in a pivotal Phase 3 study and long-term safety trial to assess Reviva’s new chemical …

Month: February 2022